Frequently Asked Questions (FAQ)

AfriMeds Sudan Co. Ltd. operates in full compliance with the National Medicines and Poisons Board (NMPB) of Sudan and the Federal Ministry of Health. All imported pharmaceuticals must possess an authentic Certificate of Pharmaceutical Product (CPP) and batch-specific Certificate of Analysis (CoA) from WHO-GMP compliant facilities.

Sudan regularly experiences ambient temperatures exceeding 42°C. We safeguard thermo-sensitive biologics, vaccines, and insulin through active refrigerated transport containers equipped with multi-point calibrated electronic dataloggers. Our primary warehouse facilities feature dual-redundant backup power generators and automated SMS temperature excursion alerts.

Manufacturers can submit their product portfolios and registration dossiers directly through our Partnership Portal or email info@afrimeds.net. Our regulatory pharmacists conduct preliminary CTD dossier evaluations within 5 business days and provide a structured market entry proposal.

AfriFlow™ encompasses precision gravity IV infusion sets, vented burette infusion systems (100ml / 150ml), and blood transfusion sets with 200μm particulate filters. AfriJect™ includes 3-part sterile hypodermic syringes (1ml to 50ml) manufactured from medical-grade polypropylene with ultra-sharp siliconized needles ensuring patient comfort.

Reports of adverse events or quality complaints are triaged immediately by our Qualified Person for Pharmacovigilance (QPPV). In compliance with national reporting timelines, urgent safety alerts are forwarded to the NMPB and the originating manufacturer, and affected batches can be placed under digital quarantine across all regional hubs within 12 hours.

Hospitals and medical procurement officers can reach our sales desk directly via phone/WhatsApp at +249 120 270 270 or by filling out the inquiry form on our Contact Page. Institutional volume price schedules and product sample specifications are issued within 24 hours.